Your browser doesn't support javascript.
loading
Transcriptional programming of dendritic cells for enhanced MHC class II antigen presentation.
Vander Lugt, Bryan; Khan, Aly A; Hackney, Jason A; Agrawal, Smita; Lesch, Justin; Zhou, Meijuan; Lee, Wyne P; Park, Summer; Xu, Min; DeVoss, Jason; Spooner, Chauncey J; Chalouni, Cecile; Delamarre, Lelia; Mellman, Ira; Singh, Harinder.
Afiliação
  • Vander Lugt B; Department of Discovery Immunology, Genentech, South San Francisco, California, USA.
  • Khan AA; Institute for Systems and Genomics Biology and Department of Human Genetics, The University of Chicago, Chicago, Illinois, USA.
  • Hackney JA; Department of Bioinformatics and Computational Biology, Genentech, South San Francisco, California, USA.
  • Agrawal S; Department of Discovery Immunology, Genentech, South San Francisco, California, USA.
  • Lesch J; Department of Translational Immunology, Genentech, South San Francisco, California, USA.
  • Zhou M; Department of Translational Immunology, Genentech, South San Francisco, California, USA.
  • Lee WP; Department of Translational Immunology, Genentech, South San Francisco, California, USA.
  • Park S; Department of Translational Immunology, Genentech, South San Francisco, California, USA.
  • Xu M; Department of Translational Immunology, Genentech, South San Francisco, California, USA.
  • DeVoss J; Department of Translational Immunology, Genentech, South San Francisco, California, USA.
  • Spooner CJ; Department of Discovery Immunology, Genentech, South San Francisco, California, USA.
  • Chalouni C; Department of Research Oncology, Genentech, South San Francisco, California, USA.
  • Delamarre L; Department of Research Oncology, Genentech, South San Francisco, California, USA.
  • Mellman I; Department of Research Oncology, Genentech, South San Francisco, California, USA.
  • Singh H; 1] Department of Discovery Immunology, Genentech, South San Francisco, California, USA. [2].
Nat Immunol ; 15(2): 161-7, 2014 Feb.
Article em En | MEDLINE | ID: mdl-24362890
ABSTRACT
CD11b(+) dendritic cells (DCs) seem to be specialized for presenting antigens via major histocompatibility (MHC) class II complexes to stimulate helper T cells, but the genetic and regulatory basis for this is not established. Conditional deletion of Irf4 resulted in loss of CD11b(+) DCs, impaired formation of peptide-MHC class II complexes and defective priming of helper T cells but not of cytotoxic T lymphocyte (CTL) responses. Gene expression and chromatin immunoprecipitation followed by deep sequencing (ChIP-Seq) analyses delineated an IRF4-dependent regulatory module that programs enhanced MHC class II antigen presentation. Expression of the transcription factor IRF4 but not of IRF8 restored the ability of IRF4-deficient DCs to efficiently process and present antigen to MHC class II-restricted T cells and promote helper T cell responses. We propose that the evolutionary divergence of IRF4 and IRF8 facilitated the specialization of DC subsets for distinct modes of antigen presentation and priming of helper T cell versus CTL responses.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Dendríticas / Linfócitos T Citotóxicos / Antígenos de Histocompatibilidade Classe II / Linfócitos T Auxiliares-Indutores / Apresentação de Antígeno / Fatores Reguladores de Interferon Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Dendríticas / Linfócitos T Citotóxicos / Antígenos de Histocompatibilidade Classe II / Linfócitos T Auxiliares-Indutores / Apresentação de Antígeno / Fatores Reguladores de Interferon Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article